McMaster University engineers have devised a way to make testing for new drugs more efficient and affordable, and reduce the time for helpful medications to reach the public
Chemical Engineering Associate Professor Todd Hoare and Rabia Mateen, a PhD candidate in Biomedical Engineering, have created a printed paper-based device that can speed up and improve the accuracy of the drug screening process. Their work, which could also be used to diagnose diseases, identify environmental contaminants and pinpoint biological warfare agents, was published in Nature Communications in February.
Currently, drug testing is done in multiple stages, with the first stage involving testing thousands of drug candidates in rapid succession to see how well they bind, block or degrade a molecule of interest to the target disease. Subsequent stages involve more extensive testing of drugs that show promise in this first step.
However, the way this initial first screen is now done results in many inaccurate results, with as many as 95% of drug candidates having no chance of becoming a useful drug. In most cases, these inaccuracies arise from the candidate drugs sticking together during the screen to create particles that physically, instead of chemically, block the activity of the molecule targeted by the drug. Such inaccuracies are only now discovered in the slower and more expensive second stage of screening, resulting in significant time and money wasted during the drug discovery process.
Hoare and Mateen have come up with a way to improve the first stage of testing by using a new printable hydrogel, a network of polymers used in everything from contact lenses to disposable diapers. The thin layers of printed hydrogels can form a cage around the target molecule so drug particles formed can’t access the target molecule and trigger the inaccurate result. Instead, only drugs that chemically bind to the target molecule (the ones that could become practical drugs) are allowed into the hydrogel to give a positive result. The printed device developed is inexpensive and can be used directly in drug screening, improving accuracy without requiring a significant change in how drug screening is now done. As an added benefit, the same sensitivity can be achieved using much less sample volume, further reducing the cost of the screen.
“We had already developed the printing method, but were not sure what to do with the materials,” Mateen said. “Reading about this significant issue in the area of drug screening made me realize that these materials could directly address this problem in a simple and effective way.”
The researchers expect this to make testing more affordable and to speed up the discovery of new drugs. In addition, to help address the surge of antibiotic resistance, the technology can also help to more quickly identify “helper drugs” that can make even drug-resistant bacteria susceptible to our current antibiotics.
“As the next step, we are looking for industry partners to prove the effectiveness of our technology on a full-scale screen of thousands of molecules that can help to extend the lifetime of our current antibiotics,” Hoare said. “We are optimistic this approach can help to bring new effective drugs to patients faster than is currently possible”.
The Latest on: Drug discovery
Discovery Channel Announces OPERATION THAI CAVE RESCUE Documentary In the Works
on July 11, 2018 at 11:32 am
ITN Productions makes major global series and specials such as new Netflix hit series "Drug Lords", "Killer INSTINCT with Chris Hansen" (Discovery ID), "Elizabeth" (Channel 5 / SBS), "Flight 370: The ... […]
New protocol produces large numbers of mature human podocytes, enabling kidney disease modeling, drug discovery
on July 11, 2018 at 8:22 am
Human stem cells are of great interest in the fields of regenerative medicine and medical research because they reproduce indefinitely and can differentiate into every other cell type found in the bod... […]
New computational method for drug discovery
on July 11, 2018 at 7:52 am
HITS researchers developed tauRAMD, a tool to predict drug-target residence times from short simulations. The method is illustrated on the cover page of July 2018 issue of the Journal of Chemical Theo... […]
Perlara announces n=1 drug discovery pact with Mission: Cure
on July 11, 2018 at 4:13 am
SAN FRANCISCO, July 11, 2018 /PRNewswire/ -- Perlara, a rare diseases drug discovery platform company partnering with highly motivated families, foundations and drug developers, today announced a Perl... […]
Discovery Sets Thai Cave Special From ‘Drug Lords’ Producer ITN Productions
on July 10, 2018 at 1:31 pm
EXCLUSIVE: The Thai cave rescue has dominated the news in the past few days and now Discovery and ITN Productions have set a documentary on the miraculous rescue. The factual broadcaster has ordered t... […]
Nanomedical Diagnostics Launches New Graphene Biosensor for Validating Primary Screen Hits During Early Stage Drug Discovery
on July 10, 2018 at 12:47 am
False positives are common when using labeled biochemical assays to measure high-concentration interactions. SCOOH Agile biosensors present a possible solution. SAN DIEGO, July 10, 2018 /PRNewswire-PR... […]
The Global Market for Computational Medicine and Drug Discovery Software was Estimated to be $5.2 Billion in 2015 and is Projected to Escalate to $7.1 Billion by 2021 ...
on July 9, 2018 at 10:39 am
DUBLIN--(BUSINESS WIRE)--The "Computational Medicine and Drug Discovery Software Market: By Tools; By Application & By Geography - Forecast 2014-2020" report has been added to ResearchAndMarkets.com's ... […]
Drug Discovery Outsourcing Market – segments and sub-segments
on July 8, 2018 at 11:21 pm
Drug discovery outsourcing involves a process of inventing a new medicine in the field of pharmaceuticals, biotechnology, and pharmacology. Drug discovery outsourcing is a complex, lengthy, and expens... […]
Drugmakers Call Experimental Alzheimer’s Drug Study Positive
on July 6, 2018 at 11:55 am
according to a 2017 report by the Alzheimer’s Drug Discovery Foundation. Lon S. Schneider, an Alzheimer’s researcher at the University of Southern California’s Keck School of Medicine, warned against ... […]
Automating molecule design to speed up drug development
on July 6, 2018 at 3:42 am
Drug discovery relies on lead optimization. In this process, chemists select a target ("lead") molecule with known potential to combat a specific disease, then tweak its chemical properties for higher ... […]
via Google News and Bing News